default author photo

Guillaume Martin-Blondel

Université de Toulouse - Service des Maladies Infectieuses et Tropicales

Toulouse

France

Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity)

Toulouse

France

SCHOLARLY PAPERS

4

DOWNLOADS

673

TOTAL CITATIONS

4

Scholarly Papers (4)

Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial

Number of pages: 39 Posted: 27 May 2021
Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, University of Claude Bernard Lyon 1, Université Libre de Bruxelles (ULB), National Institute for Health Research (NIHR) - Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Université de Lille, University of Paris, ANRS-MIE, University of Paris - INSERM, Université de Rennes 1 - INSERM, Hôpital Bichat, APHP, Université de Rennes 1 - CHU de Rennes, Hôpital Bichat, APHP, Hôpital Bichat, APHP, ANRS-MIE, Hôpital Bichat, APHP, Hôpital Bichat, APHP, Bichat-Claude Bernard Hospital, Université de Lille, Université de Lille, Hospices Civils de Lyon - Service de Médecine Intensive-Réanimation, Hospices Civils de Lyon - Medical Intensive Care Unit, Université de Lorraine - CHRU de Nancy - Service des Maladies Infectieuses et Tropicales, Université de Lorraine - CHRU de Nancy - Service des Maladies Infectieuses et Tropicales, University of Lorraine - University Hospital of Nancy - Medical Intensive Care Unit, CHU de Nantes, CHU de Nantes, CHU de Nantes, University Picardie Jules Verne, CHU Amiens-Picardie - Département de Pneumologie, Amiens Picardie University Hospital - Intensive Care Unit, University Hospital of Reims - Department of Infectious Diseases, University of Reims Champagne-Ardenne, University of Strasbourg - Department of Infectious and Tropical Diseases, CHU Strasbourg - Department of Tropical and Infectious Diseases, Nouvel Hôpital Civil, CHU Strasbourg, Department of Infectious Diseases, Hospital and University of Montpellier, University of Montpellier - Department of Intensive Care Medicine, Sorbonne University - Infectious Disease Department, Université de Toulouse - Service des Maladies Infectieuses et Tropicales, Université de Toulouse - CHU de Toulouse, CHU Martinique, CHU Martinique, Dijon University Hospital - Clinical Epidemiology Unit, University of Burgundy Franche-Comté - LipSTIC LabEx, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Saint Etienne - Department of Hygiene and Infectious Diseases, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, Université de Rennes 1 - CHU de Rennes, CHR Metz-Thionville, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, University Hospital of Henri-Mondor, APHP, CHRU Tours, Centre Hospitalier Régional et Universitaire de Besançon, Cayenne Hospital, Bicêtre University Hospital, Croix Rousse Hospital, Université Libre de Bruxelles (ULB), Centro Hospitalar Universitário Lisboa Norte (CHLN), Centro Hospitalar Universitário Lisboa Norte (CHLN), Medical University of Innsbruck - Division of Intensive Care and Emergency Medicine, Centre Hospitalier Luxembourg, CHR de la Citadelle, Paracelsus Medical University Salzburg, Paracelsus Medical University Salzburg, Université de Paris, RENARCI - Réseau national de recherche clinique en infectiologie, São João Universitary Hospital Center - Department of Intensive Care, Government of Portugal - Unidade Local de Saúde de São João, University of Claude Bernard Lyon 1, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Infection, Antimicrobials, Modelisation, Evolution (IAME), Hôpital Bichat, APHP and Hôpital Bichat, APHP
Downloads 231 (330,938)

Abstract:

Loading...

Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial

Number of pages: 39 Posted: 14 Jun 2021
Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, University of Claude Bernard Lyon 1, Université Libre de Bruxelles (ULB), National Institute for Health Research (NIHR) - Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Université de Lille, University of Paris, ANRS, University of Paris - INSERM, Université de Rennes 1 - INSERM, Hôpital Bichat, APHP, Université de Rennes 1 - CHU de Rennes, Hôpital Bichat, APHP, Hôpital Bichat, APHP, ANRS-MIE, Hôpital Bichat, APHP, Hôpital Bichat, APHP, Hopital Bichat Claude Bernard, Université de Lille, Université de Lille, Hospices Civils de Lyon - Service de Médecine Intensive-Réanimation, Hospices Civils de Lyon - Medical Intensive Care Unit, Université de Lorraine - CHRU de Nancy - Service des Maladies Infectieuses et Tropicales, Université de Lorraine - CHRU de Nancy - Service des Maladies Infectieuses et Tropicales, University of Lorraine - University Hospital of Nancy - Medical Intensive Care Unit, CHU de Nantes, CHU de Nantes, CHU de Nantes, University Picardie Jules Verne, CHU Amiens-Picardie - Département de Pneumologie, Amiens Picardie University Hospital - Intensive Care Unit, University Hospital of Reims - Department of Infectious Diseases, University of Reims Champagne-Ardenne, University of Strasbourg - Department of Infectious and Tropical Diseases, CHU Strasbourg - Department of Tropical and Infectious Diseases, Nouvel Hôpital Civil, CHU Strasbourg, Department of Infectious Diseases, Hospital and University of Montpellier, University of Montpellier - Department of Intensive Care Medicine, Sorbonne University - Infectious Disease Department, Université de Toulouse - Service des Maladies Infectieuses et Tropicales, Université de Toulouse - CHU de Toulouse, CHU Martinique, CHU Martinique, Dijon University Hospital - Clinical Epidemiology Unit, University of Burgundy Franche-Comté - LipSTIC LabEx, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Saint Etienne - Department of Hygiene and Infectious Diseases, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, Université de Rennes 1 - CHU de Rennes, CHR Metz-Thionville, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, University Hospital of Henri-Mondor, APHP, CHRU Tours, Centre Hospitalier Régional et Universitaire de Besançon, Cayenne Hospital, Bicêtre University Hospital, Croix Rousse Hospital, Université Libre de Bruxelles (ULB), Centro Hospitalar Universitário Lisboa Norte (CHLN), Centro Hospitalar Universitário Lisboa Norte (CHLN), Medical University of Innsbruck - Division of Intensive Care and Emergency Medicine, Centre Hospitalier Luxembourg, CHR de la Citadelle, Paracelsus Medical University Salzburg, Paracelsus Medical University Salzburg, Université de Paris, RENARCI - Réseau national de recherche clinique en infectiologie, São João Universitary Hospital Center - Department of Intensive Care, Government of Portugal - Unidade Local de Saúde de São João, University of Claude Bernard Lyon 1, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Infection, Antimicrobials, Modelisation, Evolution (IAME), Hôpital Bichat, APHP and Hôpital Bichat, APHP
Downloads 212 (359,157)

Abstract:

Loading...

2.

Human NLRP1 Is a Sensor of 3CL Proteases from Pathogenic Coronaviruses in Lung Epithelial Cells

Number of pages: 58 Posted: 22 Oct 2021
University of Toulouse - Institute of Pharmacology and Structural Biology (IPBS), Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, University Grenoble Alpes - Institute of Structural Biology (IBS), Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, InvivoGen, University of Montpellier - Institut de Recherche en Infectiologie de Montpellier (IRIM), Agency for Science, Technology and Research (A*STAR) - A*STAR Skin Research Laboratories, University of Paris - Laboratory of Human Genetics of Infectious Diseases, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, InvivoGen, InvivoGen, affiliation not provided to SSRN, Rockefeller University - St. Giles Laboratory of Human Genetics of Infectious Diseases, University of Paris - Laboratory of Human Genetics of Infectious Diseases, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, University of Montpellier - Institut de Recherche en Infectiologie de Montpellier (IRIM), Agency for Science, Technology and Research (A*STAR) - A*STAR Skin Research Laboratories, Université de Toulouse - Service des Maladies Infectieuses et Tropicales, University of Toulouse - Toulouse NeuroImaging Center, University of Paris - Laboratory of Human Genetics of Infectious Diseases, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Agency for Science, Technology and Research (A*STAR) - Institute of Medical Biology, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, InvivoGen and University of Toulouse - Institute of Pharmacology and Structural Biology (IPBS)
Downloads 89 (747,755)

Abstract:

Loading...

SARS-CoV-2/ 3CL proteases/ NLRP1 inflammasome/ Epithelial cells / Gasdermins / Pyroptosis

3.

Human NLRP1 Is a Sensor of Pathogenic Coronavirus 3CL Proteases in Lung Epithelial Cells

Number of pages: 65 Posted: 10 Jan 2022
University of Toulouse - Institute of Pharmacology and Structural Biology (IPBS), Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, University Grenoble Alpes - Institute of Structural Biology (IBS), University of Cambridge - Molecular Immunity Unit, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, InvivoGen, University of Montpellier - Institut de Recherche en Infectiologie de Montpellier (IRIM), Agency for Science, Technology and Research (A*STAR) - A*STAR Skin Research Laboratories, University of Paris - Laboratory of Human Genetics of Infectious Diseases, University of Cambridge - Department of Veterinary Medicine, University of Cambridge - Biological and Soft Systems, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, InvivoGen, InvivoGen, affiliation not provided to SSRN, Rockefeller University - St. Giles Laboratory of Human Genetics of Infectious Diseases, University of Cambridge - Biological and Soft Systems, University of Paris - Laboratory of Human Genetics of Infectious Diseases, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, University of Cambridge - Department of Veterinary Medicine, University of Cambridge - Molecular Immunity Unit, University of Montpellier - Institut de Recherche en Infectiologie de Montpellier (IRIM), Agency for Science, Technology and Research (A*STAR) - A*STAR Skin Research Laboratories, Université de Toulouse - Service des Maladies Infectieuses et Tropicales, Université de Toulouse - Critical Care Unit, University of Paris - Laboratory of Human Genetics of Infectious Diseases, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, Agency for Science, Technology and Research (A*STAR) - Institute of Medical Biology, Université de Toulouse - Institut de Pharmacologie et de Biologie Structurale, InvivoGen and University of Toulouse - Institute of Pharmacology and Structural Biology (IPBS)
Downloads 76 (830,555)
Citation 2

Abstract:

Loading...

SARS-CoV-2/ 3CL proteases/ NLRP1 inflammasome/ Epithelial cells / Gasdermins / Pyroptosis

4.

Increased Risk of Severe COVID-19 in Hospitalized Patients With SARS-CoV-2 Variant of Concern Alpha Infection in France: A Multicentre Matched Cohort Study With Retrospective Data Collection

Number of pages: 20 Posted: 14 Jun 2021
Université de Toulouse - Service des Maladies Infectieuses et Tropicales, Hopital Bichat Claude Bernard, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Université de Paris - Laboratoire de Virologie, Université de Rennes 1 - CHU de Rennes, Hospices Civils de Lyon, Université de Toulouse - CHU de Toulouse, Hôpital Avicenne (APHP), Sorbonne University - Hôpital Tenon - Service des Maladies Infectieuses et Tropicales, Université Paris VI Pierre et Marie Curie - Hôpital Saint-Antoine, Hopital Bichat Claude Bernard, Ambroise Paré Hospital (AP-HP), Centre Hospitalier Universitaire de Nîmes - Service des Maladies Infectieuses et Tropicales, Sorbonne University, Sorbonne University, Université de Lille, Université de Paris - Laboratoire de Virologie and Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP
Downloads 65 (924,743)
Citation 2

Abstract:

Loading...

COVID-19; SARS-CoV-2; Variant of concern Alpha; severity